Dataset from A Randomized, Single Blind, 3-Period, 3-Treatment, Single-dose, Crossover Study to Assess the Relative Bioavailability of BGF Propellant 1 and BGF Propellant 2 Compared With BGF MDI HFA in Healthy Subjects
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008229
下载链接
链接失效反馈官方服务：
资源简介：
The study will evaluate bioavailability, pharmacokinetics, safety, and tolerability of
budesonide, glycopyrronium and formoterol (BGF) metered dose inhaler (MDI) formulated with 3
different propellants: Propellant 1 (Treatment A [test]), Propellant 2 (Treatment B [test])
and Hydrofluoroalkane (HFA) (Treatment C [reference]).
创建时间：
2025-07-07
